Feasibility of the Modified Confusion Assessment Method for the Emergency Department (mCAM-ED)

February 3, 2014 updated by: Christian Nickel, University Hospital, Basel, Switzerland

Pilot Study on the Feasibility of the Modified Confusion Assessment Method for the Emergency Department (mCAM-ED)

Delirium is common in older emergency department (ED) patients and often remains unrecognized. Existing instruments to detect delirium are often time consuming and therefore not feasible in the busy ED setting In this study the investigators tested the feasibility of the newly developed modified confusion assessment method (mCAM-ED).

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

340

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Basel, Switzerland, 4031
        • University Hospital Basel

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

The samples consisted of consecutive ED patients.

Description

Inclusion Criteria:

  • patients aged 65 or older

Exclusion Criteria:

  • patients treated in the resuscitation room
  • patients transferred or discharged within 2 hours of arrival
  • patients with insufficient proficiency in the German language
  • patients with an inability to communicate (e.g. aphasic patients)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
pre-test group
All patients aged 65 or older presenting to the ED during the pre-test period
post-test period
All patients aged 65 or older presenting to the ED in the post-test period

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
delirium
Time Frame: two hours after ED admission
Delirium was assessed by research assistants using the mCAM-ED. Patients with a positive delirium diagnosis were presented to a senior emergency physician (PI) who served as the reference standard. The final delirium diagnosis was based on the DSM IV criteria
two hours after ED admission

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
adherence of ED staff to mCAM-ED algorithm
Time Frame: At patient discharge or transfer from ED (average 4 hours after presentation)
Adherence was achieved when the mCAM-ED result was documented by the ED nurses.
At patient discharge or transfer from ED (average 4 hours after presentation)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Christian H Nickel, MD, University Hospital, Basel, Switzerland

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2013

Primary Completion (ACTUAL)

August 1, 2013

Study Registration Dates

First Submitted

January 31, 2014

First Submitted That Met QC Criteria

February 3, 2014

First Posted (ESTIMATE)

February 4, 2014

Study Record Updates

Last Update Posted (ESTIMATE)

February 4, 2014

Last Update Submitted That Met QC Criteria

February 3, 2014

Last Verified

February 1, 2014

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Delirium

3
Subscribe